These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 94114

  • 1. Inhibitory action of 6-ethyl-3-(1H-tetrazol-5-YL)chromone (AA-344) on IgE, IgGa- or chemical agent-induced histamine release from isolated rat mast cells.
    Saijo T, Ashida Y, Kuriki H, Kanno M, Maki Y.
    Jpn J Pharmacol; 1979 Aug; 29(4):531-40. PubMed ID: 94114
    [Abstract] [Full Text] [Related]

  • 2. Antiallergic action of 6-ethyl-3-(1h-tetrazol-5-YL) chromone (AA-344) on immediate hypersensitivity reaction in rats.
    Kuriki H, Saijo T, Maki Y, Kanno M.
    Jpn J Pharmacol; 1979 Jun; 29(3):385-97. PubMed ID: 43912
    [Abstract] [Full Text] [Related]

  • 3. Anti-allergic action of 6-ethyl-3-(1H-tetrazol-5-YL) chromone (AA-344) in rats. II. Effect of AA-344 on histamine release from rat peritoneal exudate cells.
    Azuma Y, Yokoyama T, Fukita T, Takeda Y, Takagi N.
    Gifu Shika Gakkai Zasshi; 1985 Feb; 12(1):71-7. PubMed ID: 2411784
    [No Abstract] [Full Text] [Related]

  • 4. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y, Abe T, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. On the mechanism of dextran-induced histamine secretion from rat peritoneal mast cells.
    Thompson HL, Leoutsakos A, Pearce FL.
    Agents Actions; 1987 Apr; 20(3-4):169-71. PubMed ID: 2440262
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of traxanox sodium on IgE-mediated histamine release from passively-sensitized mast cells of the rat in vitro.
    Goto K, Hisadome M, Terasawa M.
    Int Arch Allergy Appl Immunol; 1982 Apr; 68(4):332-7. PubMed ID: 6178699
    [Abstract] [Full Text] [Related]

  • 8. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A, Coutts S, Pruss T, Jones H, Neiss E, Weinryb I.
    Biochem Pharmacol; 1987 Mar 01; 36(5):663-72. PubMed ID: 2435293
    [Abstract] [Full Text] [Related]

  • 9. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
    Kuriyama K, Hiyama Y, Ito K.
    Jpn J Pharmacol; 1989 Jun 01; 50(2):111-8. PubMed ID: 2475659
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of anti-allergic agent NCO-650 on histamine release induced by various secretagogues.
    Takei M, Matumoto T, Endo K, Muramatu M.
    Agents Actions; 1988 Aug 01; 25(1-2):17-21. PubMed ID: 2461059
    [Abstract] [Full Text] [Related]

  • 11. Histamine release induced by dextran: the nature of the dextran receptor.
    Moodley I, Mongar JL, Foreman JC.
    Eur J Pharmacol; 1982 Sep 10; 83(1-2):69-81. PubMed ID: 6182010
    [Abstract] [Full Text] [Related]

  • 12. Effect of an active metabolite of the antiallergic agent tazanolast on histamine release from rat mast cells.
    Kamei C, Mio M, Yoshida T, Saito Y, Toyoda Y, Tsuriya Y.
    Arzneimittelforschung; 1997 Apr 10; 47(4):390-4. PubMed ID: 9150859
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cAMP increase by an anti-allergic agent, NCO-650, during histamine release.
    Takei M, Matumoto T, Endo K, Muramatu M.
    Int Arch Allergy Appl Immunol; 1989 Apr 10; 88(4):377-80. PubMed ID: 2470687
    [Abstract] [Full Text] [Related]

  • 14. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester.
    Agata M, Goto H, Tsuriya Y, Tachibana K, Kuroda T.
    Jpn J Pharmacol; 1982 Aug 10; 32(4):689-97. PubMed ID: 6182323
    [Abstract] [Full Text] [Related]

  • 15. The effect of rat mast cell sensitization with mouse IgE antibody on anaphylactic histamine release by anti-mouse IgE and Con A.
    Brzezińska-Błaszczyk E, Wyczółkowska J.
    Arch Immunol Ther Exp (Warsz); 1985 Aug 10; 33(4):531-8. PubMed ID: 2417574
    [Abstract] [Full Text] [Related]

  • 16. Histamine releasers and rat mast cells.
    West GB.
    Int Arch Allergy Appl Immunol; 1983 Aug 10; 72(3):284-6. PubMed ID: 6194123
    [Abstract] [Full Text] [Related]

  • 17. Role of cyclic AMP during histamine release. Histamine release is not directly related to increase in cyclic AMP levels in rat mast cells activated by concanavalin A, anti-IgE, antigen, prostaglandin D2 and isoproterenol.
    Takei M, Matumoto T, Itoh T, Endo K, Muramatu M.
    Biol Chem Hoppe Seyler; 1988 Aug 10; 369(8):765-73. PubMed ID: 2463844
    [Abstract] [Full Text] [Related]

  • 18. Selective inhibition by vasocortin of histamine release induced by dextran and concanavalin-A from rat peritoneal cells.
    Carnuccio R, Di Rosa M, Ialenti A, Iuvone T, Sautebin L.
    Br J Pharmacol; 1989 Sep 10; 98(1):32-4. PubMed ID: 2478246
    [Abstract] [Full Text] [Related]

  • 19. Electron microscopic studies on the inhibition of degranulation of rat mast cells by a novel anti-allergic agent, PTPC.
    Ohashi T, Watanabe A, Nishigaki T, Azuma H.
    Jpn J Pharmacol; 1994 Sep 10; 66(1):7-16. PubMed ID: 7532245
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of histamine release from rat isolated peritoneal mast cells by dextran: the role of immunoglobulin E.
    Hanahoe TH.
    Agents Actions; 1984 Apr 10; 14(3-4):468-74. PubMed ID: 6203369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.